Alibaba Health Information Technology logo

Alibaba Health Information Technology

Asia, Beijing, China, Beijing

Description

AliHealth is a company that helps people get health insurance and get treatment as well.

Investor Profile

Alibaba Health Information Technology has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biotechnology, Health Diagnostics, Oncology.

Stage Focus

  • Series C (67%)
  • Series B (33%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Health Diagnostics
  • Oncology
  • Health Care
  • Life Science
  • Medical
  • Biopharma
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alibaba Health Information Technology frequently co-invest with?

Sharewin Investment
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Baidu Ventures
Asia, Beijing, China, Beijing
Co-Investments: 2
CCB Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Fortune Capital
North America, Florida, United States, Coral Gables
Co-Investments: 1
Jinmao Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Junci Investment
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CCB International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 2
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 2
Harvest Capital
North America, New Hampshire, United States, Concord
Co-Investments: 1
Fortune Venture Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1

What are some of recent deals done by Alibaba Health Information Technology?

XellSmart

Minhang, Shanghai, China

Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.

BiopharmaBiotechnologyPharmaceutical
Series BOct 21, 2024
Amount Raised: $14,046,917
Geneplus-Beijing Co. Ltd.

Huakang, Anhui, China

Provider of gene sequencing and detection solutions used in cancer research and treatment.

BiotechnologyHealth DiagnosticsOncology
Series CJul 22, 2021
Amount Raised: $115,907,089
Beijing Gene+ Technology

Changping, Beijing, China

Beijing Gene+, also known as Beijing Gene Plus, provides gene testing services for cancer prevention

Health CareLife ScienceMedical
Series CJul 22, 2021
Amount Raised: $115,907,089

Find More Investors Like Alibaba Health Information Technology

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Alibaba Health Information Technology | Pipeseed